Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Bone density

From Wikipedia, the free encyclopedia
(Redirected fromBone mineral density)
Amount of bone mineral in bone tissue
A scanner used to measure bone density usingdual energy X-ray absorptiometry

Bone density, orbone mineral density, is the amount ofbone mineral inbone tissue. Theconcept is ofmass of mineral pervolume of bone (relating todensity in thephysics sense), althoughclinically it is measured by proxy according tooptical density per square centimetre ofbone surface uponimaging.[1] Bone density measurement is used in clinical medicine as an indirect indicator ofosteoporosis andfracture risk. It is measured by a procedure calleddensitometry, often performed in theradiology ornuclear medicine departments ofhospitals orclinics. The measurement is painless and non-invasive and involves lowradiation exposure. Measurements are most commonly made over thelumbar spine and over the upper part of thehip.[2] The forearm may be scanned if the hip and lumbar spine are not accessible.

There is astatistical association between poor bone density and higher probability of fracture. Fractures of the legs andpelvis due to falls are a significantpublic health problem, especially in elderly women, leading to substantial medical costs, inability to live independently and even risk of death.[3] Bone density measurements are used to screen people for osteoporosis risk and to identify those who might benefit from measures to improve bone strength.

Testing

[edit]

A bone density test may detectosteoporosis orosteopenia.[4] The usual response to either of these indications is consultation with a physician.[4] Bone density tests are not recommended for people without risk factors for weak bones,[5][4] which is more likely to result in unnecessary treatment rather than discovery of a weakness.[4]

Indications for testing

[edit]

The risk factors for low bone density and primary considerations for a bone density test include:

  • females age 65 or older.[4]
  • males age 70 or older.[4]
  • people over age 50 with:
    • previous bone fracture from minor trauma.[4]
    • rheumatoid arthritis.[4]
    • low body weight.[4]
    • a parent with a hip fracture.[4]
  • individuals withvertebral abnormalities.[6]
  • individuals receiving, or planning to receive, long-term glucocorticoid (steroid) therapy.[6]
  • individuals with primaryhyperparathyroidism.[6]
  • individuals being monitored to assess the response or efficacy of an approved osteoporosis drug therapy.[6]
  • whenandrogen deprivation therapy is being planned forprostate cancer.
  • individuals with a history of eating disorders.[6]

Other considerations that are related to risk of low bone density and the need for a test include smoking habits, drinking habits, the long-term use of corticosteroid drugs, and a vitamin D deficiency.[4]

Test result terms

[edit]

Results of the test are reported in three forms:

  • Measured areal density in g cm−2.
  • Z-score: the number of standard deviations above or below the mean for the patient's age, sex and ethnicity.
  • T-score: the number of standard deviations above or below the mean for a healthy 30-year-old adult of the same sex and ethnicity as the patient.

Types of tests

[edit]
Illustration of Bone Densitometry Scan

While there are many types of bone mineral density tests, all are non-invasive. The tests differ according to which bones are measured to determine the test result.

These tests include:

DXA is the most commonly used testing method as of 2016[update].[7] The DXA test works by measuring a specificbone or bones, usually the spine, hip, and wrist. The density of these bones is then compared with an average index based on age, sex, and size. The resulting comparison is used to determine the risk for fractures and the stage of osteoporosis (if any) in an individual.

Quantitative ultrasound (QUS) has been described as a more cost-effective approach for measuring bone density, as compared to DXA.[8]

Average bone mineral density = BMC / W [g/cm2]

  • BMC = bone mineral content = g/cm
  • W = width at the scanned line

Interpretation

[edit]

Results are generally scored by two measures, theT-score and theZ-score. Scores indicate the amount one's bone mineral density varies from the mean. Negative scores indicate lower bone density, and positive scores indicate higher.

Less than 0.5% of patients who underwentDXA-scanning were found to have a T- or Z-score of more than +4.0, often the cause of an unusuallyhigh bone mass (HBM) and associated with mild skeletaldysplasia and the inability tofloat in water.[9]

T-score

[edit]

The T-score is the relevant measure when screening for osteoporosis. It is the bone mineral density at the site when compared to the "young normal reference mean". It is a comparison of a patient's bone mineral density to that of a healthy 30-year-old.[10] The US standard is to use data for a 30-year-old of the same sex and ethnicity, but the WHO recommends using data for a 30-year-old white female for everyone.[11] Values for 30-year-olds are used in post-menopausal women and men over age 50 because they better predict risk of future fracture.[12] The criteria of theWorld Health Organization are:[13]

  • Normal is a T-score of −1.0 or higher[14]
  • Osteopenia is defined as between −1.0 and −2.5
  • Osteoporosis is defined as −2.5 or lower, meaning a bone density that is two and a half standard deviations below the mean of a 30-year-old man/woman.
Hip fractures per 1000 patient-years[15]
WHO categoryAge 50–64Age > 64Overall
Normal5.39.46.6
Osteopenia11.419.615.7
Osteoporosis22.446.640.6

Z-score

[edit]

The Z-score for bone density is the comparison to the "age-matched normal" and is usually used in cases of severe osteoporosis. This is thestandard score or number ofstandard deviations a patient's bone mineral density differs from the average for their age, sex, and ethnicity. This value is used in premenopausal women, men under the age of 50, and in children and adolescents.[12][16] It is most useful when the score is less than 2 standard deviations below this normal. In this setting, it is helpful to scrutinize for coexisting illnesses or treatments that may contribute to osteoporosis such asglucocorticoid therapy,hyperparathyroidism, oralcoholism.

Prevention

[edit]

To prevent low bone density it is recommended to have sufficientcalcium andvitamin D.[17][18] Sufficient calcium is defined as 1,000 mg per day, increasing to 1,200 mg for women above 50 and men above 70.[18] Sufficient vitamin D is defined as 600IUs per day for adults 19 to 70, increasing to 800 IUs per day for those over 71.[18] Exercise, especially weight-bearing and resistance exercises are most effective for building bone. Weight-bearing exercise includes walking, jogging, dancing, and hiking. Resistance exercise is often accomplished through lifting weights.[19] Other therapies, such asestrogens (e.g.,estradiol,conjugated estrogens),selective estrogen receptor modulators (e.g.,raloxifene,bazedoxifene), andbisphosphonates (e.g.,alendronic acid,risedronic acid), can also be used to improve or maintain bone density.Tobacco use and excessivealcohol consumption have detrimental effects on bone density.[20][18] Excessive alcohol consumption is defined as more than onestandard-sized alcoholic beverage per day for women, and drinking two or more alcoholic beverages per day for men.[18]

Genetics

[edit]

Bone mineral density is highly variable between individuals. While there are many environmental factors that affect bone mineral density, genetic factors play the largest role.[7][21] Bone mineral density variation has been estimated to have 0.6–0.8heritability factor, meaning that 60–80% of its variation is inherited from parents.[22] Because of the heritability of bone mineral density, family history of fractures is considered as a risk factor for osteoporosis.[23] Bone mineral density ispolygenic and many of the genetic mechanisms remain poorly understood.[21]

Genetic diseases associated with bone mineral density

[edit]

There are several rare genetic diseases that have been associated with pathologic changes in bone mineral density. The table summarizes these diseases:[24][23]

DiseaseGene affectedInheritanceSource
Osteogenesis imperfectaCOLIA1Autosomal recessive[24][23]
Osteogenesis imperfectaCOLIA2Autosomal recessive[24][23]
Osteoporosis pseudoglioma syndromeLRP5Autosomal recessive[23]
OsteopetrosisTCIRGIAutosomal recessive[23]
Camurati-Engelmann diseaseTGFβ-1Autosomal recessive[23]
Van Buchem diseaseSOSTAutosomal recessive[23]
Severe infantile osteopetrosisCLCN7Autosomal recessive[23]

References

[edit]
  1. ^Bone+Density at the U.S. National Library of MedicineMedical Subject Headings (MeSH)
  2. ^Cole RE (June 2008)."Improving clinical decisions for women at risk of osteoporosis: dual-femur bone mineral density testing".J Am Osteopath Assoc.108 (6):289–95.PMID 18587077.
  3. ^"Preventing Falls and Related Fractures".NIH Osteoporosis and Related Bone Diseases National Resource Center. National Institute for Health. Retrieved2021-03-12.
  4. ^abcdefghijkConsumer Reports;American Academy of Family Physicians (May 2012),"Bone-density tests: When you need them – and when you don't"(PDF),Choosing Wisely: an initiative of theABIM Foundation,Consumer Reports, archived fromthe original(PDF) on March 4, 2016, retrievedAugust 14, 2012
  5. ^American Academy of Family Physicians,"Five Things Physicians and Patients Should Question"(PDF),Choosing Wisely: an initiative of theABIM Foundation, presented byABIM Foundation,American Academy of Family Physicians, archived fromthe original(PDF) on June 24, 2012, retrievedAugust 14, 2012
  6. ^abcde"Bone Mass Measurement".NOF. Archived fromthe original on 2008-03-07. Retrieved2008-03-20.
  7. ^abGoolsby, Marci A.; Boniquit, Nicole (2016)."Bone Health in Athletes".Sports Health.9 (2):108–117.doi:10.1177/1941738116677732.PMC 5349390.PMID 27821574.
  8. ^"Bone densitometry". Retrieved2008-09-02.
  9. ^Gregson CL, Steel SA, O'Rourke KP, Allan K, Ayuk J, Bhalla A, Clunie G, Crabtree N, Fogelman I, Goodby A, Langman CM, Linton S, Marriott E, McCloskey E, Moss KE, Palferman T, Panthakalam S, Poole KE, Stone MD, Turton J, Wallis D, Warburton S, Wass J, Duncan EL, Brown MA, Davey-Smith G, Tobias JH (February 2012)."'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass".Osteoporos Int.23 (2):643–54.doi:10.1007/s00198-011-1603-4.PMC 3261396.PMID 21455762.
  10. ^"Bone Density Scan: MedlinePlus Medical Test".medlineplus.gov. Retrieved2020-10-29.
  11. ^"T and Z scores". University of Washington Bone Physics. 2011-07-29. Retrieved2013-06-22.
  12. ^abRichmond, Bradford (2007-11-13)."Osteoporosis and bone mineral density". American College of Radiology. Archived fromthe original on 2008-09-17. Retrieved2008-05-11.
  13. ^WHO Scientific Group on the Prevention and Management of Osteoporosis (2003)."Prevention and management of osteoporosis : report of a WHO scientific group"(PDF). Retrieved2007-05-31.
  14. ^"Bone Mass Measurement: What the Numbers Mean".NIH Osteoporosis and Related Bone Diseases National Resource Center. National Institute for Health. Retrieved2021-03-12.
  15. ^Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007)."Low bone mineral density and fracture burden in postmenopausal women".Canadian Medical Association Journal.177 (6):575–80.doi:10.1503/cmaj.070234.PMC 1963365.PMID 17846439.
  16. ^Bachrach LK (February 2005). "Assessing bone health in children: who to test and what does it mean?".Pediatr Endocrinol Rev.2 (Suppl 3):332–6.PMID 16456501.
  17. ^Lawrence, Jean."Building Stronger Bones".WebMD. Retrieved2020-04-20.
  18. ^abcde"How to keep your bones healthy".Mayo Clinic. Retrieved2020-04-20.
  19. ^"Exercise for Your Bone Health".NIH Osteoporosis and Related Bone Diseases National Resource Center. National Institute for Health. Retrieved2020-11-09.
  20. ^"Smoking and Bone Health".NIH Osteoporosis and Related Bone Diseases National Resource Center. National Institute for Health. Retrieved2022-09-19.
  21. ^abYang, Tie-Lin; Shen, Hui; Liu, Anqi; Dong, Shan-Shan; Zhang, Lei; Deng, Fei-Yan; Zhao, Qi; Deng, Hong-Wen (February 2020)."A road map for understanding molecular and genetic determinants of osteoporosis".Nature Reviews Endocrinology.16 (2):91–103.doi:10.1038/s41574-019-0282-7.PMC 6980376.PMID 31792439.
  22. ^Peacock, Munro; Turner, Charles H.; Econs, Michael J.; Foroud, Tatiana (2002-06-01)."Genetics of Osteoporosis".Endocrine Reviews.23 (3):303–326.doi:10.1210/edrv.23.3.0464.PMID 12050122.
  23. ^abcdefghiHuang, Qing-Yang; Kung, Annie Wai Chee (2006-08-01)."Genetics of osteoporosis".Molecular Genetics and Metabolism.88 (4):295–306.doi:10.1016/j.ymgme.2006.04.009.PMID 16762578.
  24. ^abcMarom, Ronit; Rabenhorst, Brien M.; Morello, Roy (2020-10-01)."Management of Endocrine Disease: Osteogenesis imperfecta: an update on clinical features and therapies".European Journal of Endocrinology.183 (4):R95 –R106.doi:10.1530/EJE-20-0299.PMC 7694877.PMID 32621590.
Physiology ofbone andcartilage
Bone
Cartilage
Joint
Teeth
Retrieved from "https://en.wikipedia.org/w/index.php?title=Bone_density&oldid=1276086110"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp